Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 490

1.

Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy.

Karaa A, Haas R, Goldstein A, Vockley J, Weaver WD, Cohen BH.

Neurology. 2018 Apr 3;90(14):e1212-e1221. doi: 10.1212/WNL.0000000000005255. Epub 2018 Mar 2. Erratum in: Neurology. 2018 Apr 3;90(14 ):669.

2.

Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial.

Held C, White HD, Stewart RAH, Budaj A, Cannon CP, Hochman JS, Koenig W, Siegbahn A, Steg PG, Soffer J, Weaver WD, Östlund O, Wallentin L; STABILITY Investigators.

J Am Heart Assoc. 2017 Oct 24;6(10). pii: e005077. doi: 10.1161/JAHA.116.005077.

3.

Role of Viral Hemorrhagic Septicemia Virus Matrix (M) Protein in Suppressing Host Transcription.

Ke Q, Weaver W, Pore A, Gorgoglione B, Wildschutte JH, Xiao P, Shepherd BS, Spear A, Malathi K, Stepien CA, Vakharia VN, Leaman DW.

J Virol. 2017 Sep 12;91(19). pii: e00279-17. doi: 10.1128/JVI.00279-17. Print 2017 Oct 1.

4.

Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.

Lindholm D, James SK, Bertilsson M, Becker RC, Cannon CP, Giannitsis E, Harrington RA, Himmelmann A, Kontny F, Siegbahn A, Steg PG, Storey RF, Velders MA, Weaver WD, Wallentin L; PLATO Investigators.

Clin Chem. 2017 Feb;63(2):573-584. doi: 10.1373/clinchem.2016.261271. Epub 2016 Dec 8.

5.

Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial).

Daaboul Y, Korjian S, Weaver WD, Kloner RA, Giugliano RP, Carr J, Neal BJ, Chi G, Cochet M, Goodell L, Michalak N, Rusowicz-Orazem L, Alkathery T, Allaham H, Routray S, Szlosek D, Jain P, Gibson CM.

Am J Cardiol. 2016 Sep 1;118(5):625-31. doi: 10.1016/j.amjcard.2016.06.025. Epub 2016 Jun 15.

PMID:
27392509
6.

Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study.

Meredith IT, Tanguay JF, Kereiakes DJ, Cutlip DE, Yeh RW, Garratt KN, Lee DP, Steg PG, Weaver WD, Holmes DR Jr, Brindis RG, Trebacz J, Massaro JM, Hsieh WH, Mauri L; DAPT Study Investigators.

Circulation. 2016 May 3;133(18):1772-82. doi: 10.1161/CIRCULATIONAHA.115.016783. Epub 2016 Mar 18. Erratum in: Circulation. 2016 May 31;133(22):e671.

7.

Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomes.

Vavalle JP, van Diepen S, Clare RM, Hochman JS, Weaver WD, Mehta RH, Pieper KS, Patel MR, Patel UD, Armstrong PW, Granger CB, Lopes RD.

Am Heart J. 2016 Mar;173:57-66. doi: 10.1016/j.ahj.2015.12.001. Epub 2015 Dec 11.

PMID:
26920597
8.

EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention.

Gibson CM, Giugliano RP, Kloner RA, Bode C, Tendera M, Jánosi A, Merkely B, Godlewski J, Halaby R, Korjian S, Daaboul Y, Chakrabarti AK, Spielman K, Neal BJ, Weaver WD.

Eur Heart J. 2016 Apr 21;37(16):1296-303. doi: 10.1093/eurheartj/ehv597. Epub 2015 Nov 19.

PMID:
26586786
9.

Response to letters regarding article, "prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement".

Garratt KN, Weaver WD, Jenkins RG, Pow TK, Mauri L, Kereiakes DJ, Winters KJ, Christen T, Allocco DJ, Lee DP.

Circulation. 2015 Sep 29;132(13):e166-7. doi: 10.1161/CIRCULATIONAHA.115.016779. No abstract available.

10.

Accelerated wound healing by injectable microporous gel scaffolds assembled from annealed building blocks.

Griffin DR, Weaver WM, Scumpia PO, Di Carlo D, Segura T.

Nat Mater. 2015 Jul;14(7):737-44. doi: 10.1038/nmat4294. Epub 2015 Jun 1.

11.

The impact of extreme-risk cases on hospitals' risk-adjusted percutaneous coronary intervention mortality ratings.

Sherwood MW, Brennan JM, Ho KK, Masoudi FA, Messenger JC, Weaver WD, Dai D, Peterson ED.

JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):10-6. doi: 10.1016/j.jcin.2014.07.025. Epub 2014 Dec 10.

12.

Identification of hospital outliers in bleeding complications after percutaneous coronary intervention.

Hess CN, Rao SV, McCoy LA, Neely ML, Singh M, Spertus JA, Krone RJ, Weaver WD, Peterson ED.

Circ Cardiovasc Qual Outcomes. 2015 Jan;8(1):15-22. doi: 10.1161/CIRCOUTCOMES.113.000749. Epub 2014 Nov 25.

13.

Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement.

Garratt KN, Weaver WD, Jenkins RG, Pow TK, Mauri L, Kereiakes DJ, Winters KJ, Christen T, Allocco DJ, Lee DP.

Circulation. 2015 Jan 6;131(1):62-73. doi: 10.1161/CIRCULATIONAHA.114.013570. Epub 2014 Nov 16.

14.

Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry.

Yeh RW, Czarny MJ, Normand SL, Kereiakes DJ, Holmes DR Jr, Brindis RG, Weaver WD, Rumsfeld JS, Roe MT, Kim S, Driscoll-Shempp P, Mauri L.

Circ Cardiovasc Qual Outcomes. 2015 Jan;8(1):96-102. doi: 10.1161/CIRCOUTCOMES.114.001239. Epub 2014 Nov 16.

15.

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.

O'Donoghue ML, Braunwald E, White HD, Lukas MA, Tarka E, Steg PG, Hochman JS, Bode C, Maggioni AP, Im K, Shannon JB, Davies RY, Murphy SA, Crugnale SE, Wiviott SD, Bonaca MP, Watson DF, Weaver WD, Serruys PW, Cannon CP; SOLID-TIMI 52 Investigators, Steen DL.

JAMA. 2014 Sep 10;312(10):1006-15. doi: 10.1001/jama.2014.11061. Erratum in: JAMA. 2014 Oct 8;312(14):1473. Dylan P. Steen[corrected to Dylan L. Steen].

PMID:
25173516
16.

Sugar additives improve signal fidelity for implementing two-phase resorufin-based enzyme immunoassays.

Sandoz PA, Chung AJ, Weaver WM, Di Carlo D.

Langmuir. 2014 Jun 17;30(23):6637-43. doi: 10.1021/la5004484. Epub 2014 Jun 4.

PMID:
24870310
17.

Automated single-cell motility analysis on a chip using lensfree microscopy.

Pushkarsky I, Liu Y, Weaver W, Su TW, Mudanyali O, Ozcan A, Di Carlo D.

Sci Rep. 2014 Apr 17;4:4717. doi: 10.1038/srep04717. Erratum in: Sci Rep. 2014;4:6279. Lyb, Yunbo [corrected to Liu, Yunbo].

18.

Endoscopic ultrasound-guided fine needle aspiration improves the pre-operative diagnostic yield of solid-pseudopapillary neoplasm of the pancreas: an international multicenter case series (with video).

Law JK, Stoita A, Wever W, Gleeson FC, Dries AM, Blackford A, Kiswani V, Shin EJ, Khashab MA, Canto MI, Singh VK, Lennon AM.

Surg Endosc. 2014 Sep;28(9):2592-8. doi: 10.1007/s00464-014-3508-8. Epub 2014 Apr 10. Erratum in: Surg Endosc. 2014 Sep;28(9):2599. Weaver, Wallia [corrected to Wever, Wallia].

PMID:
24718662
19.

Darapladib for preventing ischemic events in stable coronary heart disease.

STABILITY Investigators, White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen MF, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim HS, Koenig W, Linhart A, Lonn E, López-Sendón J, Manolis AJ, Mohler ER 3rd, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse HF, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L.

N Engl J Med. 2014 May 1;370(18):1702-11. doi: 10.1056/NEJMoa1315878. Epub 2014 Mar 30.

20.

Well-plate mechanical confinement platform for studies of mechanical mutagenesis.

Kittur H, Weaver W, Di Carlo D.

Biomed Microdevices. 2014 Jun;16(3):439-47. doi: 10.1007/s10544-014-9846-4.

PMID:
24619125
21.

Small telescopes, big rewards.

Weaver WB.

Science. 2014 Mar 7;343(6175):1076. doi: 10.1126/science.343.6175.1076-a. No abstract available.

PMID:
24604179
22.

Advances in high-throughput single-cell microtechnologies.

Weaver WM, Tseng P, Kunze A, Masaeli M, Chung AJ, Dudani JS, Kittur H, Kulkarni RP, Di Carlo D.

Curr Opin Biotechnol. 2014 Feb;25:114-23. doi: 10.1016/j.copbio.2013.09.005. Epub 2013 Dec 18. Review.

23.

Research highlights: microfluidics meets big data.

Tseng P, Weaver WM, Masaeli M, Owsley K, Di Carlo D.

Lab Chip. 2014 Mar 7;14(5):828-32. doi: 10.1039/c4lc90001d.

PMID:
24473594
24.

Cost analysis of endovenous catheter ablation versus surgical stripping for treatment of superficial venous insufficiency and varicose vein disease.

Lin JC, Nerenz DR, Migliore P, Young R, Shepard AD, Weaver WD.

J Vasc Surg Venous Lymphat Disord. 2014 Jan;2(1):98-103. doi: 10.1016/j.jvsv.2013.08.005. Epub 2013 Oct 25.

PMID:
26992979
25.

Response to letters regarding article, "comparison of clinical interpretation with visual assessment and quantitative coronary angiography in patients undergoing percutaneous coronary intervention in contemporary practice: the assessing angiography (A2) project".

Nallamothu BK, Spertus JA, Lansky AJ, Cohen DJ, Jones PG, Kureshi F, Dehmer GJ, Drozda JP Jr, Walsh MN, Brush JE Jr, Koenig GC, Waites TF, Gantt DS, Kichura G, Chazal RA, O'Brien PK, Valentine CM, Rumsfeld JS, Reiber JH, Elmore JG, Krumholz RA, Weaver WD, Krumholz HM.

Circulation. 2013 Dec 17;128(24):e463-4. doi: 10.1161/CIRCULATIONAHA.113.005507. No abstract available.

26.

Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study.

Bagai A, Armstrong PW, Stebbins A, Mahaffey KW, Hochman JS, Weaver WD, Patel MR, Granger CB, Lopes RD.

Am Heart J. 2013 Nov;166(5):913-9. doi: 10.1016/j.ahj.2013.08.006. Epub 2013 Sep 24.

PMID:
24176448
27.

Size-selective collection of circulating tumor cells using Vortex technology.

Sollier E, Go DE, Che J, Gossett DR, O'Byrne S, Weaver WM, Kummer N, Rettig M, Goldman J, Nickols N, McCloskey S, Kulkarni RP, Di Carlo D.

Lab Chip. 2014 Jan 7;14(1):63-77. doi: 10.1039/c3lc50689d. Epub 2013 Sep 23.

PMID:
24061411
28.

Using augmented reality as a clinical support tool to assist combat medics in the treatment of tension pneumothoraces.

Wilson KL, Doswell JT, Fashola OS, Debeatham W, Darko N, Walker TM, Danner OK, Matthews LR, Weaver WL.

Mil Med. 2013 Sep;178(9):981-5. doi: 10.7205/MILMED-D-13-00074.

PMID:
24005547
29.

Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry).

Brennan JM, Curtis JP, Dai D, Fitzgerald S, Khandelwal AK, Spertus JA, Rao SV, Singh M, Shaw RE, Ho KK, Krone RJ, Weintraub WS, Weaver WD, Peterson ED; National Cardiovascular Data Registry.

JACC Cardiovasc Interv. 2013 Aug;6(8):790-9. doi: 10.1016/j.jcin.2013.03.020.

30.

Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction.

Chakrabarti AK, Feeney K, Abueg C, Brown DA, Czyz E, Tendera M, Janosi A, Giugliano RP, Kloner RA, Weaver WD, Bode C, Godlewski J, Merkely B, Gibson CM.

Am Heart J. 2013 Apr;165(4):509-514.e7. doi: 10.1016/j.ahj.2012.12.008. Epub 2013 Feb 15.

PMID:
23537966
31.

Comparison of clinical interpretation with visual assessment and quantitative coronary angiography in patients undergoing percutaneous coronary intervention in contemporary practice: the Assessing Angiography (A2) project.

Nallamothu BK, Spertus JA, Lansky AJ, Cohen DJ, Jones PG, Kureshi F, Dehmer GJ, Drozda JP Jr, Walsh MN, Brush JE Jr, Koenig GC, Waites TF, Gantt DS, Kichura G, Chazal RA, O'Brien PK, Valentine CM, Rumsfeld JS, Reiber JH, Elmore JG, Krumholz RA, Weaver WD, Krumholz HM.

Circulation. 2013 Apr 30;127(17):1793-800. doi: 10.1161/CIRCULATIONAHA.113.001952. Epub 2013 Mar 7.

32.

The NCDR CathPCI Registry: a US national perspective on care and outcomes for percutaneous coronary intervention.

Moussa I, Hermann A, Messenger JC, Dehmer GJ, Weaver WD, Rumsfeld JS, Masoudi FA.

Heart. 2013 Mar;99(5):297-303. doi: 10.1136/heartjnl-2012-303379. Epub 2013 Jan 15. Review.

PMID:
23322530
33.

The forgotten MASH surgeon: the story of Alvin Vincent Blount Jr, MD.

Wilson KL, DeBeatham WL, Danner OK, Matthew LR, Bacon LN, Weaver WL.

J Natl Med Assoc. 2012 Mar-Apr;104(3-4):221-3. No abstract available.

34.

Increased asymmetric and multi-daughter cell division in mechanically confined microenvironments.

Tse HT, Weaver WM, Di Carlo D.

PLoS One. 2012;7(6):e38986. doi: 10.1371/journal.pone.0038986. Epub 2012 Jun 25.

35.

Intrinsic particle-induced lateral transport in microchannels.

Amini H, Sollier E, Weaver WM, Di Carlo D.

Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11593-8. doi: 10.1073/pnas.1207550109. Epub 2012 Jul 3.

36.

Fluid flow induces biofilm formation in Staphylococcus epidermidis polysaccharide intracellular adhesin-positive clinical isolates.

Weaver WM, Milisavljevic V, Miller JF, Di Carlo D.

Appl Environ Microbiol. 2012 Aug;78(16):5890-6. doi: 10.1128/AEM.01139-12. Epub 2012 Jun 15.

37.

Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights.

van Diepen S, Widimsky P, Lopes RD, White KR, Weaver WD, Van de Werf F, Ardissino D, van't Hof AW, Armstrong PW, Granger CB.

Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):437-44. doi: 10.1161/CIRCOUTCOMES.112.965160. Epub 2012 May 15.

38.

Current status of preventive cardiology training among United States cardiology fellowships and comparison to training guidelines.

Pack QR, Keteyian SJ, McBride PE, Weaver WD, Kim HE.

Am J Cardiol. 2012 Jul 1;110(1):124-8. doi: 10.1016/j.amjcard.2012.02.059. Epub 2012 Apr 4.

PMID:
22482864
39.

International variation in and factors associated with hospital readmission after myocardial infarction.

Kociol RD, Lopes RD, Clare R, Thomas L, Mehta RH, Kaul P, Pieper KS, Hochman JS, Weaver WD, Armstrong PW, Granger CB, Patel MR.

JAMA. 2012 Jan 4;307(1):66-74. doi: 10.1001/jama.2011.1926.

PMID:
22215167
40.

Prevalence, determinants, and clinical significance of cardiac troponin-I elevation in individuals admitted for a hypertensive emergency.

Afonso L, Bandaru H, Rathod A, Badheka A, Ali Kizilbash M, Zmily H, Jacobsen G, Chattahi J, Mohamad T, Koneru J, Flack J, Weaver WD.

J Clin Hypertens (Greenwich). 2011 Aug;13(8):551-6. doi: 10.1111/j.1751-7176.2011.00476.x. Epub 2011 Jun 27.

41.

Appropriateness of percutaneous coronary intervention.

Chan PS, Patel MR, Klein LW, Krone RJ, Dehmer GJ, Kennedy K, Nallamothu BK, Weaver WD, Masoudi FA, Rumsfeld JS, Brindis RG, Spertus JA.

JAMA. 2011 Jul 6;306(1):53-61. doi: 10.1001/jama.2011.916.

42.

Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.

Hudson MP, Armstrong PW, O'Neil WW, Stebbins AL, Weaver WD, Widimsky P, Aylward PE, Ruzyllo W, Holmes D, Mahaffey KW, Granger CB.

Circ Cardiovasc Qual Outcomes. 2011 Mar;4(2):183-92. doi: 10.1161/CIRCOUTCOMES.110.945311. Epub 2011 Feb 8.

43.

Dynamics of gas-phase trichloramine (NCl3) in chlorinated, indoor swimming pool facilities.

Weng SC, Weaver WA, Afifi MZ, Blatchley TN, Cramer JS, Chen J, Blatchley ER 3rd.

Indoor Air. 2011 Oct;21(5):391-9. doi: 10.1111/j.1600-0668.2011.00710.x. Epub 2011 Mar 14.

PMID:
21251074
44.

The effects of shear stress on isolated receptor-ligand interactions of Staphylococcus epidermidis and human plasma fibrinogen using molecularly patterned microfluidics.

Weaver WM, Dharmaraja S, Milisavljevic V, Di Carlo D.

Lab Chip. 2011 Mar 7;11(5):883-9. doi: 10.1039/c0lc00414f. Epub 2011 Jan 20.

PMID:
21249255
45.

Sequential array cytometry: multi-parameter imaging with a single fluorescent channel.

Gossett DR, Weaver WM, Ahmed NS, Di Carlo D.

Ann Biomed Eng. 2011 Apr;39(4):1328-34. doi: 10.1007/s10439-010-0199-8. Epub 2010 Dec 7.

46.

Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis.

Steg PG, James S, Harrington RA, Ardissino D, Becker RC, Cannon CP, Emanuelsson H, Finkelstein A, Husted S, Katus H, Kilhamn J, Olofsson S, Storey RF, Weaver WD, Wallentin L; PLATO Study Group.

Circulation. 2010 Nov 23;122(21):2131-41. doi: 10.1161/CIRCULATIONAHA.109.927582. Epub 2010 Nov 8.

47.

Label-free cell separation and sorting in microfluidic systems.

Gossett DR, Weaver WM, Mach AJ, Hur SC, Tse HT, Lee W, Amini H, Di Carlo D.

Anal Bioanal Chem. 2010 Aug;397(8):3249-67. doi: 10.1007/s00216-010-3721-9. Epub 2010 Apr 25. Review.

48.

Adjunctive transcutaneous ultrasound with thrombolysis: results of the PLUS (Perfusion by ThromboLytic and UltraSound) trial.

Hudson M, Greenbaum A, Brenton L, Gibson CM, Siegel R, Reeves LR, Sala MF, McKendall G, Bluguermann J, Echt D, Ohman EM, Weaver WD.

JACC Cardiovasc Interv. 2010 Mar;3(3):352-9. doi: 10.1016/j.jcin.2009.11.020.

49.

Health care delivery system reform: accountable care organizations.

Dove JT, Weaver WD, Lewin J.

J Am Coll Cardiol. 2009 Sep 8;54(11):985-8. doi: 10.1016/j.jacc.2009.07.014. Review.

50.

Professional accountability in health system reform.

Dove JT, Weaver WD, Lewin J.

J Am Coll Cardiol. 2009 Aug 4;54(6):499-501. doi: 10.1016/j.jacc.2009.05.010.

Supplemental Content

Loading ...
Support Center